Citius Oncology, Inc. (CTOR) — Defensive Interval Ratio

Latest as of March 2026: 7 days

Citius Oncology, Inc. (CTOR) has a Defensive Interval Ratio of 7 days as of March 2026. Defensive assets of $1.08 Million (cash $-, short-term investments $-, receivables $1.08 Million) cover 7 days of daily cash needs of $161.13K/day. See Citius Oncology, Inc. current assets vs equity to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

7 days
Days of operational coverage

Defensive Assets

$1.08 Million
Cash + ST Investments + Receivables

Daily Cash Need

$161.13K
Current Liabilities ÷ 365

Current Liabilities

$58.81 Million
USD

Annual Defensive Interval Ratio for Citius Oncology, Inc. (None–None)

The table below presents the year-by-year Defensive Interval Ratio for Citius Oncology, Inc. from None to None, covering 0 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Citius Oncology, Inc. stock valuation.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)